FDA Urged To Collaborate With USPTO On Orange Book Listings, Eliminate Patent Use Codes

 
• By Brenda Sandburg
  
Patent skyline
The USPTO and FDA were advised on patent policy changes to prevent unjustified delays in competition. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet